| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q2'26 | $1.58 | - | - |
| Q1'26 | $1.63 | $1.61 | -1.1% |
| Q4'25 | $1.79 | $1.84 | +2.8% |
| Q3'25 | $1.64 | $1.86 | +13.7% |
| Q2'25 | $1.53 | $1.73 | +13.2% |
| Q1'25 | $1.57 | $1.70 | +8.6% |
| Qtr | Est | Actual | +/− |
|---|---|---|---|
| Q2'26 | $1.1B | - | - |
| Q1'26 | $1.1B | $1.1B | -1.9% |
| Q4'25 | $1.1B | $1.1B | -0.2% |
| Q3'25 | - | $1.1B | - |
| Q2'25 | - | $1.0B | - |
| Q1'25 | - | $1.0B | - |
Market Data
AKAM is currently trading at $126.41, giving Akamai Technologies, Inc. a market cap of 18.40B and a P/E ratio of 42.3. Today's range spans $125.28–$131.07, with shares opening at $130.18 and moving down $3.11 (2.4%) from the prior close. DailyIQ's technical score sits at 73/100 (BUY) with a news sentiment reading of 77/100.
Over the past year AKAM has traded between $69.78 and $165.45 - the current price is +81.2% off the 52-week low and -23.6% from the high. 34 analysts cover the stock with a Buy consensus and a mean 12-month target of $159.30 (range $87.00–$195.00), implying upside of +26.0%.
The combination of bullish technicals and bullish sentiment for Akamai Technologies, Inc. (AKAM) is the kind of setup that shows up in systematic screens before the more discretionary investors arrive. Score 73/100 (BUY), price $126.41 (in the middle of its 52-week range), sentiment 77/100. The current P/E ratio stands at 42.3. At 18.40B in Technology market cap, this large-cap name has the right size to matter to a wide range of buyers. Annual range: $69.78–$165.45.
Earnings revision cycles in large-cap Technology names tend to compound: when technicals confirm a BUY thesis (73/100) and news sentiment (77/100, bullish) supports the narrative, analyst upgrades follow price rather than lead it. At $126.41 (in the middle of its 52-week range), AKAM's position within the $69.78–$165.45 annual range suggests there's room for multiple expansion before the stock encounters meaningful technical resistance.
Sentiment gathered from recent headlines
Most recent articles, ranked by recency (click to expand).